These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 6791049)
1. Chronic valproate administration produces hepatic dysfunction and may delay brain maturation in infant mice. Thurston JH; Hauhart RE; Schulz DW; Naccarato EF; Dodson WE; Carroll JE Neurology; 1981 Sep; 31(9):1063-9. PubMed ID: 6791049 [TBL] [Abstract][Full Text] [Related]
2. A single therapeutic dose of valproate affects liver carbohydrate, fat, adenylate, amino acid, coenzyme A, and carnitine metabolism in infant mice: possible clinical significance. Thurston JH; Carroll JE; Hauhart RE; Schiro JA Life Sci; 1985 Apr; 36(17):1643-51. PubMed ID: 3921791 [TBL] [Abstract][Full Text] [Related]
4. Valproate doubles the anoxic survival time of normal developing mice: possible relevance to valproate-induced decreases in cerebral levels of glutamate and aspartate, and increases in taurine. Thurston JH; Hauhart RE Life Sci; 1989; 45(1):59-62. PubMed ID: 2501608 [TBL] [Abstract][Full Text] [Related]
5. Fuels, hormones, and liver metabolism at term and during the early postnatal period in the rat. Girard JR; Cuendet GS; Marliss EB; Kervran A; Rieutort M; Assan R J Clin Invest; 1973 Dec; 52(12):3190-200. PubMed ID: 4750449 [TBL] [Abstract][Full Text] [Related]
6. Acute effects of sodium valproate and gamma-vinyl GABA on regional amino acid metabolism in the rat brain: incorporation of 2-[14C]glucose into amino acids. Chapman AG; Riley K; Evans MC; Meldrum BS Neurochem Res; 1982 Sep; 7(9):1089-105. PubMed ID: 6817155 [TBL] [Abstract][Full Text] [Related]
7. Comparative effects of valproate and the new experimental anticonvulsant drug alpha-ethyl-alpha-methyl-thiobutyrolactone on selected metabolite levels in the plasma, livers, and brains of infant mice. Thurston JH; Hauhart RE Epilepsia; 1996 Jan; 37(1):2-5. PubMed ID: 8603619 [TBL] [Abstract][Full Text] [Related]
8. Evidence of stimulation of the gamma-aminobutyric acid shunt by valproate and E-delta 2-valproate in neonatal rat brain. Bolaños JP; Medina JM Mol Pharmacol; 1993 Mar; 43(3):487-90. PubMed ID: 8450838 [TBL] [Abstract][Full Text] [Related]
9. Valproate and myoclonus. Chapman AG Adv Neurol; 1986; 43():661-74. PubMed ID: 3080855 [TBL] [Abstract][Full Text] [Related]
11. Effect of valproate on lipogenesis in neonatal rat brain. Bolaños JP; Medina JM Biochem Pharmacol; 1993 Mar; 45(6):1283-8. PubMed ID: 8466548 [TBL] [Abstract][Full Text] [Related]
12. Valproate metabolite concentrations in brain increase with chronic administration of sodium valproate. Carl GF; DeLoach C; Patterson J Life Sci; 1985 Nov; 37(21):2029-35. PubMed ID: 3934486 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of neonatal brain fuel utilization by valproate and E-delta 2-valproate is not a consequence of the stimulation of the gamma-aminobutyric acid shunt. Bolaños JP; Medina JM Life Sci; 1994; 55(20):PL397-402. PubMed ID: 7968221 [TBL] [Abstract][Full Text] [Related]
14. [Lithium valproate: its neuropharmacological spectrum and effect on transmitter amino acid content of the brain of rats]. Kharlamov AN; Shumkova OV; Blinkova NF; Tolmacheva NS; Raevskiĭ KS Farmakol Toksikol; 1984; 47(5):11-5. PubMed ID: 6149951 [TBL] [Abstract][Full Text] [Related]
15. The activity of D- -hydroxybutyrate dehydrogenase in fetal, infant and adult rat brain and the influence of starvation. Dahlquist G; Persson U; Persson B Biol Neonate; 1972; 20(1):40-50. PubMed ID: 5027154 [No Abstract] [Full Text] [Related]
16. [Effect of sodium valproate on the mediator amino acid content in the rat brain]. Kharlamov AN; Kovalev GI; Shumkova OV Farmakol Toksikol; 1982; 45(5):31-4. PubMed ID: 6128253 [TBL] [Abstract][Full Text] [Related]
17. Temporal changes in liver, blood, and brain glucose, glycogen, and beta-hydroxybutyrate after ethanol in C57BL/6J mice. Schreiber RA; Ungar AL Subst Alcohol Actions Misuse; 1984; 5(5):255-62. PubMed ID: 6533840 [TBL] [Abstract][Full Text] [Related]
18. 2-phosphonomethyl-pentanedioic acid (glutamate carboxypeptidase II inhibitor) increases threshold for electroconvulsions and enhances the antiseizure action of valproate against maximal electroshock-induced seizures in mice. Luszczki JJ; Mohamed M; Czuczwar SJ Eur J Pharmacol; 2006 Feb; 531(1-3):66-73. PubMed ID: 16403497 [TBL] [Abstract][Full Text] [Related]
19. Beta-hydroxybutyrate reverses insulin-induced hypoglycemic coma in suckling-weanling mice despite low blood and brain glucose levels. Thurston JH; Hauhart RE; Schiro JA Metab Brain Dis; 1986 Mar; 1(1):63-82. PubMed ID: 3334063 [TBL] [Abstract][Full Text] [Related]
20. A proposed mechanism for the anticonvulsant action of valproate. Schreiber RA Med Hypotheses; 1981 Nov; 7(11):1377-87. PubMed ID: 6798375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]